Baskhanbio Pharma Inc. (XKON:354390)
South Korea
· Delayed Price · Currency is KRW 4,995.00
-5.00 (-0.10%)
At close: Apr 28, 2026
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 39.23 billion as of April 29, 2026. Its market cap has increased by 33.10% in one year.
Market Cap
39.23B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,995.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 39.23B, a decrease of -52.63%. That is a compound annual growth rate of -17.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 35.06B | 4.50% |
| Dec 30, 2025 | 33.55B | 11.42% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seoul Pharma | 33.17B |
| GeneBioTech Co. ,Ltd | 41.16B |
| ChoA Pharmaceutical Co., LTD. | 29.52B |
| Pharmsville | 28.86B |
| Daesung Microbiological Labs. | 28.65B |
| Korean Drug | 46.16B |
| HLscience | 46.75B |
| Hurum | 25.20B |